Hiroshi Imamura

Hiroshi Imamura

Auto-generated profile, based on publicly available information

Hiroshi Imamura

Department of Emergency and Critical Care Medicine Shinshu University Matsumoto City Nagano Japan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Circulation Journal
Verified
Journal Article
Closed access
HIHiroshi Imamura
Hiroshi Imamura
YSYukio Sekiguchi
Yukio Sekiguchi
TITomomi Iwashita
Tomomi Iwashita
HDHiroshi Dohgomori
Hiroshi Dohgomori
KMKatsunori Mochizuki
Katsunori Mochizuki
KOKazufumi Okamoto
Kazufumi Okamoto
Acute aortic dissection (AAD) classically presents as sudden, severe chest, back, or abdominal pain. However, there have been several documented cases presenting with atypical features. The clinical characteristics and outcomes of patients with painless AAD were investigated. The study group comprised 98 patients (53 males, 45 females; 66 ± 12 years) with AAD admitted to hospital from 2002 to 2007: 16 patients (17%) had no pain (painless group) and 82 patients had pain (painful group). In 81% of the painless group and 70% of the painful group there was a type A dissection. The painless group more frequently had a persistent disturbance of consciousness (44% vs. 6%, P < 0.001), syncope (25% vs. 1%, P < 0.001) and a focal neurologic deficit (19% vs. 2%, P = 0.006) as presenting symptoms. Imaging study findings were not significantly different. Cerebral ischemia (50% vs. 1%, P < 0.001) and cardiac tamponade (38% vs. 13%, P = 0.01) were more frequent complications in the painless group. In-hospital mortality was not significantly different (19% vs. 15%). However, the painless group had a more unfavorable functional outcome on overall performance category (P < 0.001). Painless AAD may be more frequent than previously reported. Painless AAD patients often present with a disturbance of consciousness or a neurologic deficit, and have a higher morbidity than painful AAD patients.

18 October 2013 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
GSGo Sato
Go Sato
YIYoichi Ishizaki
Yoichi Ishizaki
JYJiro Yoshimoto
Jiro Yoshimoto
HSHiroyuki Sugo
Hiroyuki Sugo
HIHiroshi Imamura
Hiroshi Imamura
SKSeiji Kawasaki
Seiji Kawasaki

1 February 2012 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HSHiroyuki Sugo
Hiroyuki Sugo
YIYoichi Ishizaki
Yoichi Ishizaki
JYJiro Yoshimoto
Jiro Yoshimoto
HIHiroshi Imamura
Hiroshi Imamura
SKSeiji Kawasaki
Seiji Kawasaki

13 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HKHirohsi Kamijo
Hirohsi Kamijo
KMKatsunori Mochizuki
Katsunori Mochizuki
YNYuta Nakamura
Yuta Nakamura
KMKotaro Mori
Kotaro Mori
MIMichitaro Ichikawa
Michitaro Ichikawa
HIHiroshi Imamura
Hiroshi Imamura
Nafamostat mesylate (NM) is a synthetic serine protease inhibitor that can be used as an anticoagulant during blood purification in critically ill patients, as well as a treatment for disseminated intravascular coagulation. Although NM has been reported to reduce the risk of bleeding during blood purification, its effect on survival outcomes of patients who received blood purification treatments is unclear. We hypothesized that administration of NM during blood purification can reduce mortality in patients with sepsis. A post hoc analysis was conducted on a nationwide retrospective registry that included data from 3195 sepsis patients registered at 42 intensive care units throughout Japan. We evaluated the effect of NM on hospital mortality and bleeding complications using propensity score matching in 1216 sepsis patients who underwent blood purification in the intensive care unit (ICU). Two-hundred-and-sixty-eight pairs of propensity score-matched patients who received NM and conventional therapy were compared. Hospital and ICU mortality rates in the NM group were significantly lower than those in the conventional therapy group. However, rates of bleeding complications did not differ significantly between the two groups. These data suggest that administration of NM improved the survival outcomes of sepsis patients who underwent blood purification in the ICU.

1 May 1998 in Cancer Letters
Verified
Journal Article
Closed access
YMYoshifumi Matsushita
Yoshifumi Matsushita
KYKiyotaka Yoshiie
Kiyotaka Yoshiie
YIYoshiro Imamura
Yoshiro Imamura
HOHiroki Ogawa
Hiroki Ogawa
HIHiroshi Imamura
Hiroshi Imamura
ESEiichi Sato
Eiichi Sato

2 June 2014 in Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
KMKatsunori Mochizuki
Katsunori Mochizuki
HIHiroshi Imamura
Hiroshi Imamura
TITomomi Iwashita
Tomomi Iwashita
KOKazufumi Okamoto
Kazufumi Okamoto
In a rural region with few medical resources, we have promoted the strategy that if an out-of-hospital cardiac arrest (OHCA) patient is likely reversible, he or she should be transported directly from the scene of cardiac arrest to the only tertiary care center where extracorporeal cardiopulmonary resuscitation (ECPR) is readily available. We investigated 1-month survival and neurological outcomes after ECPR in OHCA patients at this center. We implemented a retrospective review of OHCA patients of heterogeneous origin in whom ECPR was performed. Demographic characteristics, cardiopulmonary resuscitation, ECPR details, and neurological outcomes were evaluated. Cerebral performance categories were used to assign each patient to favorable or unfavorable outcome groups. Fifty OHCA patients underwent ECPR. Presumed causes of OHCA were cardiac etiology in 32 patients, accidental hypothermia in 7 patients, and other causes in 11 patients. Overall, 13 patients (26%) survived and 10 patients (20%) had favorable outcomes. Of the 32 patients with OHCA of cardiac origin, 5 patients (16%) had favorable outcomes. Of the seven patients with OHCA of hypothermic origin, five patients (71%) had favorable outcomes. No clinically reliable predictors to identify ECPR candidates were found. However, all nine OHCA patients over 70 years of age had unfavorable outcomes (P = 0.224). In addition, all seven patients who satisfied the basic life support termination-of-resuscitation rule had unfavorable outcomes (P = 0.319). ECPR can be a useful means to rescue OHCA patients who are unresponsive to conventional cardiopulmonary resuscitation in a rural tertiary care center, in a manner similar to that observed in the urban regions.